Carbidopa

Basic Information

Item Value
DrugBank ID DB00190
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 33

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 Rasmussen subacute encephalitis KG + DL
2 PLA2G6-associated neurodegeneration KG + DL
3 transaldolase deficiency KG + DL
4 myelitis KG + DL
5 fructose-1,6-bisphosphatase deficiency KG + DL
6 Lewy body dementia KG + DL
7 paralysis agitans, juvenile, of Hunt KG + DL
8 progressive supranuclear palsy-corticobasal syndrome KG + DL
9 X-linked intellectual disability-ataxia-apraxia syndrome KG + DL
10 X-linked intellectual disability-cerebellar hypoplasia syndrome KG + DL
11 multiple system atrophy, parkinsonian type KG + DL
12 CLCN4-related X-linked intellectual disability syndrome KG + DL
13 lethal infantile mitochondrial myopathy KG + DL
14 X-linked intellectual disability-spastic quadriparesis syndrome KG + DL
15 hydrocephaly-cerebellar agenesis syndrome KG + DL
16 NAA10-related syndrome KG + DL
17 X-linked spasticity-intellectual disability-epilepsy syndrome KG + DL
18 syndromic X-linked intellectual disability Chudley-Schwartz type KG + DL
19 intellectual disability, X-linked, syndromic KG + DL
20 MED12-related intellectual disability syndrome KG + DL
21 X-linked intellectual disability-hypotonia-movement disorder syndrome KG + DL
22 X-linked cerebral-cerebellar-coloboma syndrome syndrome KG + DL
23 Paganini-Miozzo syndrome KG + DL
24 X-linked intellectual disability, Stocco dos Santos type KG + DL
25 X-linked intellectual disability with hypopituitarism KG + DL
26 X-linked intellectual disability-precocious puberty-obesity syndrome KG + DL
27 intellectual developmental disorder, X-linked, syndromic, Hackmann-Di Donato type KG + DL
28 Prieto syndrome KG + DL
29 Basilicata-Akhtar syndrome KG + DL
30 X-linked intellectual disability-craniofacioskeletal syndrome KG + DL
31 primary progressive freezing gait KG + DL
32 holoprosencephaly 13, X-linked KG + DL
33 lissencephaly type 1 due to doublecortin gene mutation KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.